AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27042281
Drug: Insulin degludec
RxNorm normalized name: Insulin Degludec
DrugBank: Insulin degludec (DB09564)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin degludec (IDeg)
Trial: 9136839
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA, 750 mg/day)
Trial: 18272319
Drug: Ketalar (ketamine)
RxNorm normalized name: ketamine Injectable Solution [Ketalar]
DrugBank: Ketamine (DB01221)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketalar (ketamine) administered at induction until the end of surgery
Trial: 15945402
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (400 IU daily)
Trial: 26519688
Drug: Shuanghua Baihe
RxNorm normalized name: colloidal oatmeal
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shuanghua Baihe tablets
Trial: 15805377
Drug: Naloxone hydrochloride
RxNorm normalized name: Naloxone Hydrochloride
DrugBank: Naloxone (DB01183)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naloxone hydrochloride 0.01 mg/kg administered intravenously before oral administration of 1 mL of 30% glucose
Trial: 2523665
Drug: Isradipine (monotherapy)
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine (monotherapy)
Trial: 9236562
Drug: Nizatidine 225
RxNorm normalized name: Nizatidine
DrugBank: Nizatidine (DB00585)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nizatidine 225 mg
Trial: 28277352
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate (25 mg every 8 hours) plus intravenous infusion of 2 L isotonic solution
Trial: 28049170
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (500 µg twice daily) for 30 months
Trial: 10029609
Drug: Mesalamine microgranular
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mesalamine microgranular preparation, 4 g
Trial: 8296092
Drug: CVD 103-HgR
RxNorm normalized name: Vibrio cholerae CVD 103-hgr strain live antigen
DrugBank: Vibrio cholerae CVD 103-HgR strain live antigen (DB14443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVD 103-HgR vaccine
Trial: 29070637
Drug: Active photobiomodulation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active photobiomodulation therapy (PBMT)
Trial: 23856779
Drug: Deleobuvir 400
RxNorm normalized name: Deleobuvir
DrugBank: Deleobuvir (DB14850)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deleobuvir 400 mg q8h for 5 days (for patients with cirrhosis)
Trial: 20404773
Drug: Weekly newsletter
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly newsletter (comparison group)
Trial: 26711162
Drug: Nicotine Replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine Replacement Therapy (NRT)
Trial: 19887866
Drug: Capecitabine combination
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine combination chemotherapy (36% of patients, median starting dose 987 mg/m² b.i.d.)
Trial: 11113398
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive use
Trial: 2885203
Drug: Acrivastine 4
RxNorm normalized name: Acrivastine
DrugBank: Acrivastine (DB09488)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acrivastine 4 mg with alcohol 32 ml
Trial: 25823907
Drug: 4-week buprenorphine
RxNorm normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-week buprenorphine taper
Trial: 20192896
Drug: Sodium thiosulfate
RxNorm normalized name: Sodium Thiosulfate
DrugBank: Thiosulfuric acid (DB09499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium thiosulfate (STS) infusion
Trial: 25193157
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol 25 micrograms every 2 hours for a maximum of 12 doses or until active labor commences
Trial: 6128546
Drug: Albumin infusion
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin infusion
Trial: 6380205
Drug: Bromhexine (Bisolvon)
RxNorm normalized name: bromhexine
DrugBank: Bromhexine (DB09019)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromhexine (Bisolvon) 48 mg daily for 3 weeks
Trial: 11979153
Drug: Gadodiamide at
RxNorm normalized name: Gadodiamide
DrugBank: Gadodiamide (DB00225)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gadodiamide at doses of 0.1 and 0.3 mmol/kg
Trial: 19441606
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide aqueous nasal spray (TAA AQ), 110 microg once daily
Trial: 16492208
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1 g) therapy for 2 days prior to re-testing
Trial: 24681810
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR (400-800 mg/day)
Trial: 23786762
Drug: Low-fat yoghurt
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat yoghurt with 1.9 g/d plant stanols as esters
Trial: 12972102
Drug: MC-1 treatment
RxNorm normalized name: MC-1
DrugBank: MC-1 (DB05315)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MC-1 treatment
Trial: 8335204
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Heme arginate + Tin protoporphyrin)
Trial: 20973316
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (50 g as slurry with 250 ml of water)
Trial: 15692125
Drug: Nimodipine 90
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nimodipine 90 mg/d
Trial: 25968968
Drug: Home intervention
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home intervention system (HIS, OPTILOGG(®)) with a tablet computer and weight scale
Trial: 11122832
Drug: Antibody-drug conjugates
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibody-drug conjugates and immunotoxins
Trial: 21783387
Drug: Low-dose Flutamide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose Flutamide
Trial: 2252531
Drug: Patients in
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients in remission (after stopping treatment)
Trial: 8052871
Drug: Carboplatin 300
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin 300 mg/m2 day I, etoposide 140 mg/m2 days 1 through 3, and vincristine 1.4 mg/m2 days 1, 8, and 15 (CEV)
Trial: 10764680
Drug: Peroral estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peroral estradiol valerate (2 mg/d)
Trial: 12890374
Drug: Compressed air-driven
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compressed air-driven beta(2)-agonist therapy (Berotec)
Trial: 30098049
Drug: Anticholinergic exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticholinergic exposure (defined by four methods for each of four anticholinergic scales: Anticholinergic Drug Scale, Anticholinergic Cognitive Burden, Anticholinergic Risk Scale, the Durán list)
Trial: 2467136
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg daily
Trial: 24879757
Drug: Zilpaterol hydrochloride
RxNorm normalized name: zilpaterol hydrochloride
DrugBank: Zilpaterol (DB11479)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zilpaterol hydrochloride (ZH; 8.3 mg/kg of DM for 20 d with 3‐d withdrawal)
Trial: 6210661
Drug: Intravenous mezlocillin
RxNorm normalized name: mezlocillin
DrugBank: Mezlocillin (DB00948)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous mezlocillin (16 g/day)
Trial: 30390065
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (Syntocinon®, Novartis; 10 puffs = 20 international units per treatment)
Trial: 10235086
Drug: Aspirin 81
RxNorm normalized name: aspirin 81 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 81 mg/day
Trial: 30518334
Drug: Oral Fosfomycin-Trometamol
RxNorm normalized name: trometamol
DrugBank: Tromethamine (DB03754)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Fosfomycin-Trometamol
Trial: 22360134
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) pre-seasonal regimen: 5,000 AU/week for 10 weeks/year for 2 years (Group 2)
Trial: 732468
Drug: Whole-gut irrigation
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-gut irrigation with antibiotics (neomycin-bacitracin-clindamycin)
Trial: 24088534
Drug: BCG plus
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG plus single-dose rifampicin (SDR)
Trial: 26712979
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TA) 20 mg/kg diluted to 25 cc with normal saline (Group T)
Trial: 15365537
Drug: Telithromycin 800
RxNorm normalized name: Telithromycin
DrugBank: Telithromycin (DB00976)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telithromycin 800 mg once daily for 5 days
Trial: 20811918
Drug: No lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No lidocaine spray and ETTs lubricated with normal saline (Group C)
Trial: 12633548
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with perindopril (4 mg daily) and indapamide (at physician's discretion)
Trial: 3894129
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin treatment or CSII (Continuous Subcutaneous Insulin Infusion)
Trial: 3840743
Drug: Formulation N
RxNorm normalized name: N-6022
DrugBank: N-6022 (DB12206)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation N (higher plasma fenofibrate level)
Trial: 3840743
Drug: Formulation R
RxNorm normalized name: Formulation R
DrugBank: Hydrogenated palm kernel oil (DB11144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation R (lower plasma fenofibrate level)
Trial: 27835765
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine 100U/mL (Gla-100)
Trial: 15321699
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C co-infusion
Trial: 11257395
Drug: Adjuvant active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant active specific immunotherapy
Trial: 21911741
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (20,000 IU vitamin D(3) twice weekly for 6 months)
Trial: 18515735
Drug: Upfront zoledronic
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Upfront zoledronic acid (4 mg intravenously every 6 months)
Trial: 2511743
Drug: Sustained-release diltiazem
RxNorm normalized name: diltiazem
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release diltiazem 180 mg twice daily
Trial: 8115311
Drug: Isradipine plain
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine plain formulation (2.5 mg twice daily)
Trial: 10510878
Drug: Trimebutine maleate
RxNorm normalized name: Trimebutine maleate
DrugBank: Trimebutine (DB09089)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimebutine maleate (oral treatment for three weeks)
Trial: 1857516
Drug: Intravaginal 1
RxNorm normalized name: taurolidine
DrugBank: Taurolidine (DB12473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal 1 mg Gemeprost
Trial: 24683783
Drug: Intranasal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal midazolam spray
Trial: 26019183
Drug: Low-dose THC
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose THC (2.9%) without alcohol
Trial: 11864862
Drug: Dietary magnesium
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary magnesium intake of 320 mg/d (recommended dietary allowance)
Trial: 9327093
Drug: Naltrexone hydrochloride
RxNorm normalized name: Naltrexone Hydrochloride
DrugBank: Naltrexone (DB00704)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naltrexone hydrochloride (NTX) 2 mg/kg
Trial: 8847044
Drug: G-CSF therapy
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF therapy
Trial: 19327467
Drug: Nafamostat mesylate
RxNorm normalized name: mesylate
DrugBank: Nafamostat (DB12598)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Nafamostat mesylate (20 mg) with 5% dextrose solution
Trial: 19493959
Drug: Mirtazapine treatment
RxNorm normalized name: Mirtazapine
DrugBank: Mirtazapine (DB00370)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mirtazapine treatment for 8 weeks
Trial: 9129083
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF), daily treatment over a 14-day period.
Trial: 21560266
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (1 mg, pressurized metered dose inhaler)
Trial: 15910512
Drug: AR-R15896AR 350
RxNorm normalized name: AR-9281
DrugBank: AR-9281 (DB06345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AR-R15896AR 350 mg
Trial: 25896352
Drug: Liraglutide treatment
RxNorm normalized name: Liraglutide
DrugBank: Liraglutide (DB06655)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Liraglutide treatment for 10 weeks
Trial: 9014018
Drug: Biological markers
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological markers (serum GGT, ASAT, MCV, urate levels)
Trial: 7964484
Drug: T cell
RxNorm normalized name: CD4CAR T cells
DrugBank: Anti-CD4 CAR T-cell therapy (DB17281)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T cell lines from treatment-resistant Lyme arthritis
Trial: 14635010
Drug: IFN-alpha 2b
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IFN-alpha 2b 3 MU/day for 24 weeks, followed by 3 MU x 3/week for 24 weeks plus ribavirin 1-1.2 g/day for 48 weeks
Trial: 12869379
Drug: 2-week oral
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 2-week oral treatment with 3 x 5 mg/day terbutaline
Trial: 25078053
Drug: Traditional protocol
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional protocol using clomiphene citrate (CC) 100 mg/day for patients who failed the 50 mg/day treatment in the previous cycle.
Trial: 2101781
Drug: Oral captopril
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral captopril 15 min before thrombolysis (37 patients)
Trial: 9516063
Drug: Galanin infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Galanin infusion (8 microg/Kg/h) in patients with active acromegaly (group II)
Trial: 17908055
Drug: Sequential vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential vaccination
Trial: 15516645
Drug: Diethylcarbamazine and
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diethylcarbamazine and albendazole therapy (DEC/ALB)
Trial: 7639972
Drug: Intravenous ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ganciclovir 5 mg/kg once daily infused over 1 h
Trial: 11216491
Drug: Isoflavone tablets
RxNorm normalized name: Soy isoflavones
DrugBank: Isoflavone (DB12007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavone tablets
Trial: 12143204
Drug: Intravenous allopurinol
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous allopurinol
Trial: 20864251
Drug: Intravesical botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical botulinum toxin type A (BoNTA) injection, >100 U
Trial: 8435323
Drug: Oxymetholone 2
RxNorm normalized name: Oxymetholone
DrugBank: Oxymetholone (DB06412)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxymetholone 2 mg/kg/d p.o. daily for 4 months
Trial: 2991817
Drug: Org 2766
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 2766 (synthetic ACTH 4-9 analog), administered for 6 months
Trial: 7191300
Drug: triamterene preparation
RxNorm normalized name: Triamterene
DrugBank: Triamterene (DB00384)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: triamterene preparation 2
Trial: 10331109
Drug: Pindolol treatment
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pindolol treatment
Trial: 17098754
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of bone-marrow-derived progenitor cells (BMCs)
Trial: 9498433
Drug: Zalcitabine (dideoxycytidine)
RxNorm normalized name: ZALCITABINE (DIDEOXYCYTIDINE,ddC)
DrugBank: Zalcitabine (DB00943)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zalcitabine (dideoxycytidine) monotherapy
Trial: 29499855
Drug: PF-03463275 40
RxNorm normalized name: selenious acid
DrugBank: Selenious acid (DB11127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-03463275 40 mg twice a day
Trial: 24809408
Drug: Oral glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral glutamine (GL) supplementation for 7 days
Trial: 16107437
Drug: Daily tenofovir
RxNorm normalized name: Tenofovir
DrugBank: Tenofovir (DB14126)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily tenofovir HIV prophylaxis
Trial: 19503774
Drug: Active-assisted stretching
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active-assisted stretching program (AA), performed twice weekly for eight weeks
Trial: 23382539
Drug: Cardiovascular polypill
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cardiovascular polypill (aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg) taken in the evening
Trial: 23069363
Drug: Pedometer-based Green
RxNorm normalized name: Indocyanine Green
DrugBank: Indocyanine green (DB16024)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Pedometer-based Green Prescription
Trial: 19018783
Drug: Low-dose flutamide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose flutamide (62.5 mg/day; 21/28 days)
Trial: 26825666
Drug: Probiotic capsule
RxNorm normalized name: GNP Probiotic Capsule
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsule containing four bacterial strains